These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26025665)

  • 1. Presence of insulin-like growth factor binding proteins correlates with tumor-promoting effects of matrix metalloproteinase 9 in breast cancer.
    Park JH; Rasch MG; Qiu J; Lund IK; Egeblad M
    Neoplasia; 2015 May; 17(5):421-33. PubMed ID: 26025665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.
    Decock J; Hendrickx W; Thirkettle S; Gutiérrez-Fernández A; Robinson SD; Edwards DR
    Breast Cancer Res; 2015 Mar; 17(1):38. PubMed ID: 25848906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment.
    Obr AE; Kumar S; Chang YJ; Bulatowicz JJ; Barnes BJ; Birge RB; Lazzarino DA; Gallagher E; LeRoith D; Wood TL
    Breast Cancer Res; 2018 Nov; 20(1):138. PubMed ID: 30458886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
    Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
    Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo.
    Ramovs V; Secades P; Song JY; Thijssen B; Kreft M; Sonnenberg A
    Breast Cancer Res; 2019 May; 21(1):63. PubMed ID: 31101121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol promotes mammary tumor development via the estrogen pathway in estrogen receptor alpha-negative HER2/neu mice.
    Wong AW; Dunlap SM; Holcomb VB; Nunez NP
    Alcohol Clin Exp Res; 2012 Apr; 36(4):577-87. PubMed ID: 21981381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.
    Christenson JL; Butterfield KT; Spoelstra NS; Norris JD; Josan JS; Pollock JA; McDonnell DP; Katzenellenbogen BS; Katzenellenbogen JA; Richer JK
    Horm Cancer; 2017 Apr; 8(2):69-77. PubMed ID: 28194662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.
    Wellberg EA; Rudolph MC; Lewis AS; Padilla-Just N; Jedlicka P; Anderson SM
    Breast Cancer Res; 2014 Dec; 16(6):481. PubMed ID: 25472762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.
    Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P
    Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal regulation of insulin-like growth factor II and insulin-like growth factor binding protein expression by breast cancer cells in vivo: evidence for stromal epithelial interactions.
    Manni A; Badger B; Wei L; Zaenglein A; Grove R; Khin S; Heitjan D; Shimasaki S; Ling N
    Cancer Res; 1994 Jun; 54(11):2934-42. PubMed ID: 7514495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-binding proteins in R3230AC mammary tumors of intact and diabetic rats.
    Korc-Grodzicki B; Ren N; Hilf R
    Endocrinology; 1993 Nov; 133(5):2362-70. PubMed ID: 7691588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer.
    Hoenerhoff MJ; Shibata MA; Bode A; Green JE
    Transgenic Res; 2011 Apr; 20(2):247-59. PubMed ID: 20549348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.
    Aprelikova O; Tomlinson CC; Hoenerhoff M; Hixon JA; Durum SK; Qiu TH; He S; Burkett S; Liu ZY; Swanson SM; Green JE
    PLoS One; 2016; 11(5):e0155262. PubMed ID: 27171183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia.
    Gallagher EJ; Zelenko Z; Neel BA; Antoniou IM; Rajan L; Kase N; LeRoith D
    Oncogene; 2017 Nov; 36(46):6462-6471. PubMed ID: 28759039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment.
    García-Mendoza MG; Inman DR; Ponik SM; Jeffery JJ; Sheerar DS; Van Doorn RR; Keely PJ
    Breast Cancer Res; 2016 May; 18(1):49. PubMed ID: 27169366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
    Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA
    Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer.
    Denzel MS; Hebbard LW; Shostak G; Shapiro L; Cardiff RD; Ranscht B
    Clin Cancer Res; 2009 May; 15(10):3256-64. PubMed ID: 19447866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.